438 related articles for article (PubMed ID: 12145331)
1. Retinoid X receptor dominates the nuclear import and export of the unliganded vitamin D receptor.
Prüfer K; Barsony J
Mol Endocrinol; 2002 Aug; 16(8):1738-51. PubMed ID: 12145331
[TBL] [Abstract][Full Text] [Related]
2. Dimerization with retinoid X receptors promotes nuclear localization and subnuclear targeting of vitamin D receptors.
Prüfer K; Racz A; Lin GC; Barsony J
J Biol Chem; 2000 Dec; 275(52):41114-23. PubMed ID: 11001945
[TBL] [Abstract][Full Text] [Related]
3. Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation.
Bettoun DJ; Burris TP; Houck KA; Buck DW; Stayrook KR; Khalifa B; Lu J; Chin WW; Nagpal S
Mol Endocrinol; 2003 Nov; 17(11):2320-8. PubMed ID: 12893883
[TBL] [Abstract][Full Text] [Related]
4. Degradation of RXRs influences sensitivity of rat osteosarcoma cells to the antiproliferative effects of calcitriol.
Prüfer K; Schröder C; Hegyi K; Barsony J
Mol Endocrinol; 2002 May; 16(5):961-76. PubMed ID: 11981032
[TBL] [Abstract][Full Text] [Related]
5. L7 protein is a coregulator of vitamin D receptor-retinoid X receptor-mediated transactivation.
Berghöfer-Hochheimer Y; Zurek C; Wölfl S; Hemmerich P; Munder T
J Cell Biochem; 1998 Apr; 69(1):1-12. PubMed ID: 9513041
[TBL] [Abstract][Full Text] [Related]
6. Nuclear import of the retinoid X receptor, the vitamin D receptor, and their mutual heterodimer.
Yasmin R; Williams RM; Xu M; Noy N
J Biol Chem; 2005 Dec; 280(48):40152-60. PubMed ID: 16204233
[TBL] [Abstract][Full Text] [Related]
7. Retinoid X receptor isotype identity directs human vitamin D receptor heterodimer transactivation from the 24-hydroxylase vitamin D response elements in yeast.
Kephart DD; Walfish PG; DeLuca H; Butt TR
Mol Endocrinol; 1996 Apr; 10(4):408-19. PubMed ID: 8721985
[TBL] [Abstract][Full Text] [Related]
8. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D receptors from patients with resistance to 1,25-dihydroxyvitamin D3: point mutations confer reduced transactivation in response to ligand and impaired interaction with the retinoid X receptor heterodimeric partner.
Whitfield GK; Selznick SH; Haussler CA; Hsieh JC; Galligan MA; Jurutka PW; Thompson PD; Lee SM; Zerwekh JE; Haussler MR
Mol Endocrinol; 1996 Dec; 10(12):1617-31. PubMed ID: 8961271
[TBL] [Abstract][Full Text] [Related]
10. The ligand-binding domains of the thyroid hormone/retinoid receptor gene subfamily function in vivo to mediate heterodimerization, gene silencing, and transactivation.
Qi JS; Desai-Yajnik V; Greene ME; Raaka BM; Samuels HH
Mol Cell Biol; 1995 Mar; 15(3):1817-25. PubMed ID: 7862171
[TBL] [Abstract][Full Text] [Related]
11. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone.
Haussler MR; Jurutka PW; Hsieh JC; Thompson PD; Selznick SH; Haussler CA; Whitfield GK
Bone; 1995 Aug; 17(2 Suppl):33S-38S. PubMed ID: 8579895
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D receptor displays DNA binding and transactivation as a heterodimer with the retinoid X receptor, but not with the thyroid hormone receptor.
Thompson PD; Hsieh JC; Whitfield GK; Haussler CA; Jurutka PW; Galligan MA; Tillman JB; Spindler SR; Haussler MR
J Cell Biochem; 1999 Dec; 75(3):462-80. PubMed ID: 10536369
[TBL] [Abstract][Full Text] [Related]
13. Selective intranuclear redistribution of PPAR isoforms by RXR alpha.
Akiyama TE; Baumann CT; Sakai S; Hager GL; Gonzalez FJ
Mol Endocrinol; 2002 Apr; 16(4):707-21. PubMed ID: 11923467
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor activates a nuclear inhibitor of vitamin D and retinoid-X receptors.
Fernandez-Martin JL; Kurian S; Farmer P; Nanes MS
Mol Cell Endocrinol; 1998 Jun; 141(1-2):65-72. PubMed ID: 9723887
[TBL] [Abstract][Full Text] [Related]
15. Distinct retinoid X receptor activation function-2 residues mediate transactivation in homodimeric and vitamin D receptor heterodimeric contexts.
Thompson PD; Remus LS; Hsieh JC; Jurutka PW; Whitfield GK; Galligan MA; Encinas Dominguez C; Haussler CA; Haussler MR
J Mol Endocrinol; 2001 Oct; 27(2):211-27. PubMed ID: 11564604
[TBL] [Abstract][Full Text] [Related]
16. Selective effects of ligands on vitamin D3 receptor- and retinoid X receptor-mediated gene activation in vivo.
Lemon BD; Freedman LP
Mol Cell Biol; 1996 Mar; 16(3):1006-16. PubMed ID: 8622645
[TBL] [Abstract][Full Text] [Related]
17. The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators.
Tagami T; Lutz WH; Kumar R; Jameson JL
Biochem Biophys Res Commun; 1998 Dec; 253(2):358-63. PubMed ID: 9878542
[TBL] [Abstract][Full Text] [Related]
18. Two basic amino acids C-terminal of the proximal box specify functional binding of the vitamin D receptor to its rat osteocalcin deoxyribonucleic acid-responsive element.
Hsieh JC; Whitfield GK; Jurutka PW; Haussler CA; Thatcher ML; Thompson PD; Dang HT; Galligan MA; Oza AK; Haussler MR
Endocrinology; 2003 Nov; 144(11):5065-80. PubMed ID: 12960019
[TBL] [Abstract][Full Text] [Related]
19. Modulation of retinoid signalling through NGF-induced nuclear export of NGFI-B.
Katagiri Y; Takeda K; Yu ZX; Ferrans VJ; Ozato K; Guroff G
Nat Cell Biol; 2000 Jul; 2(7):435-40. PubMed ID: 10878809
[TBL] [Abstract][Full Text] [Related]
20. Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes.
Staal A; van Wijnen AJ; Birkenhäger JC; Pols HA; Prahl J; DeLuca H; Gaub MP; Lian JB; Stein GS; van Leeuwen JP; Stein JL
Mol Endocrinol; 1996 Nov; 10(11):1444-56. PubMed ID: 8923469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
